Señales en vivo de PEAR | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 abr 2023 @ 16:00):

Stats
Volumen de hoy	66.30M
Volumen promedio	10.09M
Capitalización de mercado	4.09M
EPS	$0 ( 2024-03-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0811
ATR14	$0.0310 (645.83%)

Insider Trading

Date	Person	Action	Amount	type
2023-04-10	5am Partners Iv, Llc	Sell	3 172 769	Class A Common Stock
2023-04-10	5am Partners Iv, Llc	Sell	534 855	Class A Common Stock
2023-02-15	Snow Ellen	Buy	199 864	Restricted Stock Units
2023-02-16	Snow Ellen	Buy	40 000	Restricted Stock Units
2023-02-15	Brenner Erin K.	Buy	952 380	Restricted Stock Units

INSIDER POWER
29.93
Last 97 transactions
Buy: 13 156 765 \| Sell: 6 479 057

Volumen Correlación

Largo: -0.32 (neutral)

Corto: -0.74 (moderate negative)

Signal:(22.192) Neutral

Pear Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas
VORB	0.976
BRQS	0.975
IRDM	0.974
PYR	0.972
APPS	0.97
PTE	0.97
AUPH	0.968
CYAN	0.967
TRIT	0.966
BHTG	0.966

10 Correlaciones Más Negativas
GXII	-0.982
SHLD	-0.98
CDRO	-0.977
ISEE	-0.977
CRTO	-0.975
NXGN	-0.973
TXRH	-0.973
ARYD	-0.97
APP	-0.97
ADSE	-0.969

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pear Therapeutics, Inc. Correlación - Moneda/Commodity

-0.45
( neutral )

-0.84
( strong negative )

0.00
( neutral )

-0.29
( neutral )

0.55
( weak )

0.80
( moderate )

Pear Therapeutics, Inc. Finanzas

Annual	2022
Ingresos:	$12.69M
Beneficio Bruto:	$4.51M (35.54 %)
EPS:	$-0.170

FY	2022
Ingresos:	$12.69M
Beneficio Bruto:	$4.51M (35.54 %)
EPS:	$-0.170

FY	2021
Ingresos:	$4.21M
Beneficio Bruto:	$-1.03M (-24.36 %)
EPS:	$-0.473

FY	2020
Ingresos:	$9.38M
Beneficio Bruto:	$7.67M (81.69 %)
EPS:	$-0.784

Financial Reports:

No articles found.

Pear Therapeutics, Inc.

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.